What the Texas Court’s Abortion-Pill Ruling Means for FDA

Decision to revoke approval of mifepristone could end courts’ traditional deference to regulatory agency, lawyers say

Illustration: David Fang

A federal judge’s ruling against the Food and Drug Administration’s approval of the abortion pill could weaken the agency, opening its science-based decisions to court reviews, said lawyers specializing in the matters.

The decision, if it is appealed to the Supreme Court, could also give conservative justices an opportunity to trim the power of federal agencies generally, lawyers said.

What's News

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a subscriber? Sign In

Sponsored Offers